These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3950582)

  • 61. Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing).
    Virgin HW; Bassel-Duby R; Fields BN; Tyler KL
    J Virol; 1988 Dec; 62(12):4594-604. PubMed ID: 2460637
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain).
    Ono L; Wollinger W; Rocco IM; Coimbra TL; Gorin PA; Sierakowski MR
    Antiviral Res; 2003 Nov; 60(3):201-8. PubMed ID: 14638396
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Homogeneity among Senegalese strains of yellow fever virus.
    Deubel V; Pailliez JP; Cornet M; Schlesinger JJ; Diop M; Diop A; Digoutte JP; Girard M
    Am J Trop Med Hyg; 1985 Sep; 34(5):976-83. PubMed ID: 4037185
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of administration of sodium aurothiomalate on the virulence of yellow fever viruses in adult mice.
    Gibson CA; Wills MR; Gould EA; Sanders PG; Barrett AD
    Vaccine; 1990 Dec; 8(6):590-4. PubMed ID: 2128429
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of a nuclease-resistant derivative of polyriboinosinic-polyribocytidylic acid complex on yellow fever in rhesus monkeys (Macaca mulatta).
    Stephen EL; Sammons ML; Pannier WL; Baron S; Spertzel RO; Levy HB
    J Infect Dis; 1977 Jul; 136(1):122-6. PubMed ID: 407312
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis.
    Schmaljohn AL; Johnson ED; Dalrymple JM; Cole GA
    Nature; 1982 May; 297(5861):70-2. PubMed ID: 6280072
    [No Abstract]   [Full Text] [Related]  

  • 67. BCX4430, a novel nucleoside analog, effectively treats yellow fever in a Hamster model.
    Julander JG; Bantia S; Taubenheim BR; Minning DM; Kotian P; Morrey JD; Smee DF; Sheridan WP; Babu YS
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6607-14. PubMed ID: 25155605
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Yellow fever virus. II. Factors affecting the plaque neutralization test.
    Spector SL; Tauraso NM
    Appl Microbiol; 1969 Nov; 18(5):736-43. PubMed ID: 4984200
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Engineered human immunoglobulin anti-yellow fever virus monoclonal antibodies to treat severe yellow fever.
    Leong WY
    J Travel Med; 2020 Nov; 27(7):. PubMed ID: 32946558
    [No Abstract]   [Full Text] [Related]  

  • 70. Stablity of yellow fever virus neutralising antibody titres.
    Zhao L; Miao F; Chen T; Du H; Zhao J
    Lancet Infect Dis; 2020 Feb; 20(2):166-167. PubMed ID: 32006501
    [No Abstract]   [Full Text] [Related]  

  • 71. Monoclonal Antibodies and Flaviviruses: a Possible Option?
    Mancini N
    mBio; 2022 Jun; 13(3):e0082422. PubMed ID: 35575500
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sensitive and specific monoclonal immunoassay for detecting yellow fever virus in laboratory and clinical specimens.
    Monath TP; Hill LJ; Brown NV; Cropp CB; Schlesinger JJ; Saluzzo JF; Wands JR
    J Clin Microbiol; 1986 Jan; 23(1):129-34. PubMed ID: 3700596
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Monoclonal antibodies to two bovine coronavirus glycoproteins neutralize virus infectivity.
    Deregt D; Sabara M; Babiuk LA
    Adv Exp Med Biol; 1987; 218():473-4. PubMed ID: 3434438
    [No Abstract]   [Full Text] [Related]  

  • 74. Waning immunity after single-dose yellow fever vaccination: Who needs a second shot?
    Visser LG; Veit O; Chen LH
    J Travel Med; 2019 Oct; 26(7):. PubMed ID: 30476151
    [No Abstract]   [Full Text] [Related]  

  • 75. Yellow fever virus. I. Development and evaluation of a plaque neutralization test.
    Spector S; Tauraso NM
    Appl Microbiol; 1968 Nov; 16(11):1770-5. PubMed ID: 4973067
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative immunoelectron microscopy with monoclonal antibodies on yellow fever virus-infected cells: pre-embedding labelling versus immunocryoultramicrotomy.
    Gelderblom HR; Kocks C; L'Age-Stehr J; Reupke H
    J Virol Methods; 1985 Mar; 10(3):225-39. PubMed ID: 3886683
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Arguments for a two-dose yellow fever vaccination regimen in travellers.
    Neumayr A; Stähelin C; Kuenzli E; Hatz C
    J Travel Med; 2019 Sep; 26(6):. PubMed ID: 30657977
    [No Abstract]   [Full Text] [Related]  

  • 78. Stablity of yellow fever virus neutralising antibody titres - Authors' reply.
    Domingo C; Bhat N; Ansah P; Mejía JE
    Lancet Infect Dis; 2020 Feb; 20(2):167. PubMed ID: 32006502
    [No Abstract]   [Full Text] [Related]  

  • 79. HISTOPATHOLOGY OF THE CENTRAL NERVOUS SYSTEM IN SWISS MICE INTRACEREBRALLY INOCULATED WITH 17-D STRAIN OF YELLOW FEVER VIRUS.
    DOMINGUEZ A; BARUCH E
    Am J Trop Med Hyg; 1963 Sep; 12():815-9. PubMed ID: 14070776
    [No Abstract]   [Full Text] [Related]  

  • 80. Monoclonal antibodies to HIV in a non-infected, immunised volunteer.
    Desgranges C; Boyer V; Souche S; Sprecher S; Burney A; Gallo RC; Bernard J; Reveil B; Zagury D
    Lancet; 1988 Apr; 1(8591):935-6. PubMed ID: 2895850
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.